Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 63234-80-0
2. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one
3. 3-(2-chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido[1,2-a]-pyrimidin-4-one
4. 3-(2-chloro-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one
5. 3-(2-chloroethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
6. Piperidopyrimidinone Intermediate
7. 3-(2-chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4hpyrido(1,2-a)pyrimidin-4-one
8. 2089cr1aqn
9. Mfcd06200813
10. 3-(2-chloroethyl)-2-methyl-4h,6h,7h,8h,9h-pyrido[1,2-a]pyrimidin-4-one
11. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2a)pyrimidine-4-one
12. 4h-pyrido(1,2-a)pyrimidin-4-one, 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-
13. 3-(2-chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido[1,2-a]pyrimidine-4-one
14. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidine-4-one
15. Risperidone Impurity L [ep]
16. Unii-2089cr1aqn
17. 3-(2-chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)pyrimidin-4-one
18. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-one
19. Paliperidone Impurity 3
20. Risperidone Ep Impurity L;
21. Schembl460865
22. Dtxsid00212626
23. Act04286
24. Bcp11946
25. Bbl010804
26. Stk617737
27. Zinc13723213
28. Akos005552077
29. Ac-3457
30. Cs-w014205
31. Pb10329
32. Sb10296
33. 3-2(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimdin-4-one
34. As-73540
35. Sy047063
36. A8722
37. Ft-0640879
38. Ft-0705669
39. Risperidone Impurity L [ep Impurity]
40. 1,2-benzisoxazole,4-fluoro-3-(4-piperidinyl)-
41. 234c800
42. J-510497
43. Q27253442
44. 3-(2-chloroethyl)-6,7,8,9-th-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one
45. 3-(2-chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyridino(1,2-a)-pyrimidine-4-one
46. 3-(2-chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyridino(1,2a)pyrimidine-4-one
47. 3-(2-chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido[1,2-a]-pyrimidin-4 One
48. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h- Pyrido[1,2-a]pyrimidin-4-one
49. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyridino[1,2-a]pyrimidine-4-one
50. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido [1,2-a] Pyrimidin-4-one
51. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido [1,2-a]pyrimidine-4-one
52. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido 1,2-a Pyrimidin-4-one
53. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[ 1,2-a]pyrimidin-4-one
54. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2methyl-4h-pyrido[1,2-a]pyrimidin-4-one
55. 4h-pyrido[1,2-a]pyrimidin-4-one,3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-
56. 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one, Aldrichcpr
| Molecular Weight | 226.70 g/mol |
|---|---|
| Molecular Formula | C11H15ClN2O |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 226.0872908 g/mol |
| Monoisotopic Mass | 226.0872908 g/mol |
| Topological Polar Surface Area | 32.7 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 347 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Piperidopyrimidinone Intermediate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Piperidopyrimidinone Intermediate, including repackagers and relabelers. The FDA regulates Piperidopyrimidinone Intermediate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Piperidopyrimidinone Intermediate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Piperidopyrimidinone Intermediate supplier is an individual or a company that provides Piperidopyrimidinone Intermediate active pharmaceutical ingredient (API) or Piperidopyrimidinone Intermediate finished formulations upon request. The Piperidopyrimidinone Intermediate suppliers may include Piperidopyrimidinone Intermediate API manufacturers, exporters, distributors and traders.
click here to find a list of Piperidopyrimidinone Intermediate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Piperidopyrimidinone Intermediate DMF (Drug Master File) is a document detailing the whole manufacturing process of Piperidopyrimidinone Intermediate active pharmaceutical ingredient (API) in detail. Different forms of Piperidopyrimidinone Intermediate DMFs exist exist since differing nations have different regulations, such as Piperidopyrimidinone Intermediate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Piperidopyrimidinone Intermediate DMF submitted to regulatory agencies in the US is known as a USDMF. Piperidopyrimidinone Intermediate USDMF includes data on Piperidopyrimidinone Intermediate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Piperidopyrimidinone Intermediate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Piperidopyrimidinone Intermediate suppliers with USDMF on PharmaCompass.
Piperidopyrimidinone Intermediate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Piperidopyrimidinone Intermediate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Piperidopyrimidinone Intermediate GMP manufacturer or Piperidopyrimidinone Intermediate GMP API supplier for your needs.
A Piperidopyrimidinone Intermediate CoA (Certificate of Analysis) is a formal document that attests to Piperidopyrimidinone Intermediate's compliance with Piperidopyrimidinone Intermediate specifications and serves as a tool for batch-level quality control.
Piperidopyrimidinone Intermediate CoA mostly includes findings from lab analyses of a specific batch. For each Piperidopyrimidinone Intermediate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Piperidopyrimidinone Intermediate may be tested according to a variety of international standards, such as European Pharmacopoeia (Piperidopyrimidinone Intermediate EP), Piperidopyrimidinone Intermediate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Piperidopyrimidinone Intermediate USP).
LOOKING FOR A SUPPLIER?
